EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 3.0

A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case Report

Tinashe Adrian Mazhindu, Zedias Chikwambi, Edith Matsikidze iD, Kevin V Grimes iD, Margaret Z Borok iD, Ntokozo Ndlovu, Collen Masimirembwa, Consortium for Genomics and Therapeutics in Africa

Cancer Management and Research · 2026-02 · Volume 18 · 1-8

DOI: 10.2147/cmar.s571794 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cancer Management and Research, 2026-02. Verfasst von Tinashe Adrian Mazhindu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research and Services, African Institute of Biomedical Sciences & Technology, Harare, Zimbabwe. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

fluoropyrimidinegastrointestinal cancergenetic polymorphismsprecision medicinetoxicity

Autor:innen und Institutionen

  • Department of Clinical Research and Services, African Institute of Biomedical Sciences & Technology, Harare, Zimbabwe.
  • Department of Oncology, Medical Physics and Imaging Science, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
  • Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Internal Medicine, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

ORCID-Profile: Edith Matsikidze, Kevin V Grimes, Margaret Z Borok

Zitieren

APA

Mazhindu, T. A., Chikwambi, Z., Matsikidze, E., Grimes, K. V., Borok, M. Z., Ndlovu, N., Masimirembwa, C., & Consortium for Genomics and Therapeutics in Africa (2026). A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case Report. Cancer Management and Research, Volume 18, 1-8. https://doi.org/10.2147/cmar.s571794

Vancouver

Mazhindu TA, Chikwambi Z, Matsikidze E, Grimes KV, Borok MZ, Ndlovu N, et al. A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case Report. Cancer Management and Research. 2026;Volume 18:1-8. doi:10.2147/cmar.s571794

BibTeX
@article{Mazhindu2026,
  author = {Mazhindu, Tinashe Adrian and Chikwambi, Zedias and Matsikidze, Edith and Grimes, Kevin V and Borok, Margaret Z and Ndlovu, Ntokozo and Masimirembwa, Collen and Consortium for Genomics and Therapeutics in Africa, Consortium for Genomics and Therapeutics in Africa},
  title = {A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case Report},
  journal = {Cancer Management and Research},
  year = {2026},
  volume = {Volume 18},
  pages = {1--8},
  doi = {10.2147/cmar.s571794}
}
Kostenlos starten →